The Montana Dad Who Fought Big Pharma to Get a Cancer Drug Trial

  • Few new child-focused drugs are developed every year
  • Desperate parents clash with drugmakers to get clinical trials

On a rainy morning in February 2013 at Seattle Children’s Hospital, doctors and nurses were rushing in and out of the tiny room of a 5-year-old kidney cancer patient, Stellablue, who was getting a second round of aggressive chemotherapy following a relapse.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.